UC San Francisco and OncoSec Medical Collaborate to Evaluate Investigational Combination of ImmunoPulse and Anti-PD-1 ...

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, has entered a clinical collaboration with the University of California, San



from Content Keyword RSS http://ift.tt/1zonrD2

via IFTTT